Review article: is Helicobacter pylori status relevant in the management of GORD? (Q34069835)

30 July 2017

1 reference

title

Review article: is Helicobacter pylori status relevant in the management of GORD? (English)

1 reference

Helicobacter pylori infectious disease

30 July 2017

0 references

1 reference

Vigneri S

1

1 reference

30 July 2017

Termini R

series ordinal

2

1 reference

30 July 2017

Savarino V

series ordinal

3

1 reference

30 July 2017

Pace F

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Alimentary Pharmacology & Therapeutics

30 July 2017

1 reference

30 July 2017

14 Suppl 3

1 reference

30 July 2017

31-42

1 reference

Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Reflux oesophagitis and Helicobacter pylori infection in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Non-steroidal anti-inflammatory drugs, hiatus hernia, and Helicobacter pylori, in patients with oesophageal ulceration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

The increasing frequency of adenocarcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Opposing time trends of peptic ulcer and reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Effect of a Campylobacter pylori protein on acid secretion by parietal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Campylobacter pylori is not associated with gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Transient lower esophageal sphincter relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

The effect of Helicobacter pylori eradication on gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Long-term sequelae of Helicobacter pylori gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Contribution of HLA-DQA gene to host's response against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

The effect of environmental pH on the proton motive force of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Omeprazole: Helicobacter pylori makes thee greater yet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Chronic peptic ulcer of the oesophagus and 'oesophagitis'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Corpus gastritis is protective against reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00398.X

10.1046/J.1365-2036.2000.00398.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference